As of 2025-06-03, the Intrinsic Value of Stryker Corp (SYK) is 417.74 USD. This Stryker valuation is based on the model Discounted Cash Flows (Growth Exit 5Y). With the current market price of 380.86 USD, the upside of Stryker Corp is 9.70%.
The range of the Intrinsic Value is 248.75 - 1,178.87 USD
Based on its market price of 380.86 USD and our intrinsic valuation, Stryker Corp (SYK) is undervalued by 9.70%.
| Range | Selected | Upside | |
| a | |||
| DCF (Growth 5y) | 248.75 - 1,178.87 | 417.74 | 9.7% |
| DCF (Growth 10y) | 328.59 - 1,429.31 | 529.53 | 39.0% |
| DCF (EBITDA 5y) | 214.36 - 413.36 | 309.90 | -18.6% |
| DCF (EBITDA 10y) | 292.25 - 546.17 | 410.34 | 7.7% |
| Fair Value | 72.58 - 72.58 | 72.58 | -80.94% |
| P/E | 225.03 - 352.23 | 287.55 | -24.5% |
| EV/EBITDA | 190.34 - 382.65 | 292.78 | -23.1% |
| EPV | 124.17 - 166.71 | 145.44 | -61.8% |
| DDM - Stable | 105.95 - 535.38 | 320.66 | -15.8% |
| DDM - Multi | 233.38 - 877.83 | 364.27 | -4.4% |
| Market Cap (mil) | 145,549.45 |
| Beta | 0.58 |
| Outstanding shares (mil) | 382.16 |
| Enterprise Value (mil) | 160,010.45 |
| Market risk premium | 4.60% |
| Cost of Equity | 7.10% |
| Cost of Debt | 4.28% |
| WACC | 6.81% |